Juventas Cell Therapy (Worldwide Rights of Anti-CD19 T-Cell Therapy in Tianjin City, China) is Buildings and Property in China that focus on commercialization rights business. They cover business area such as worldwide license, commercialization, right, Tianjin City, China, all phase, b-cell development, b-cell drive hematological malignancy, child, adult, relapsed B-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia.
-
Commercialization Rights
-
Building 5, No.8, Haitai Development 3rd Avenue
Huayuan Industrial Zone
Tianjin
China
Private
worldwide licensecommercializationrightTianjin CityChinaall phaseb-cell developmentb-cell drive hematological malignancychildadultrelapsed B-cell acute lymphoblastic leukemiachronic lymphocytic leukemia
* We use standard office opening hours in near Juventas Cell Therapy (Worldwide Rights of Anti-CD19 T-Cell Therapy in Tianjin City, China)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Juventas Cell Therapy (Worldwide Rights Of Anti-CD19 T-Cell Therapy In Tianjin City, China) is Buildings and Property business from China that founded in - ( years old in ), Juventas Cell Therapy (Worldwide Rights of Anti-CD19 T-Cell Therapy in Tianjin City, China) business is focusing on Commercialization Rights.
Juventas Cell Therapy (Worldwide Rights of Anti-CD19 T-Cell Therapy in Tianjin City, China) headquarter office and corporate office address is located in Building 5, No.8, Haitai Development 3rd Avenue Huayuan Industrial Zone Tianjin China.
Juventas Cell Therapy (Worldwide Rights of Anti-CD19 T-Cell Therapy in Tianjin City, China) was founded in China.
In , Juventas Cell Therapy (Worldwide Rights of Anti-CD19 T-Cell Therapy in Tianjin City, China) is currently focus on commercialization rights sector.
Above is snippet of Google Trends for "commercialization rights" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Juventas Cell Therapy (Worldwide Rights of Anti-CD19 T-Cell Therapy in Tianjin City, China), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
